← Back to Search

Web-based Prevention for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Led By Lisa A. Marsch, Ph.D.
Research Sponsored by National Development and Research Institutes, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This study will evaluate the comparative effectiveness and cost-effectiveness of a customized, interactive web-based HIV, sexually transmitted infections (STI) and hepatitis prevention intervention as compared to a traditional, educator-delivered prevention intervention. Both interventions will be offered to youth enrolled in outpatient, community-based substance abuse treatment at our collaborating treatment facilities. Outcomes to be measured include accurate HIV/disease prevention knowledge, intentions to engage in safer sex, actual HIV risk behavior, attitudes toward safer sex and self-reported substance use. The web-delivered intervention under evaluation has the potential to deliver evidence-based content at low cost without increasing demands on treatment staff time or training needs.

Eligible Conditions
  • Human Immunodeficiency Virus Infection
  • Hepatitis
  • Sexually Transmitted Diseases

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HIV risk behavior
HIV/disease prevention knowledge
behavioral intentions
Secondary outcome measures
intervention acceptability
self-reported substance use
skills acquisition

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Web-based PreventionExperimental Treatment1 Intervention
self-directed, interactive & customized web-based HIV & disease prevention education
Group II: Traditional PreventionActive Control1 Intervention
educator-delivered, small-group HIV & disease prevention education

Find a Location

Who is running the clinical trial?

National Development and Research Institutes, Inc.Lead Sponsor
37 Previous Clinical Trials
12,826 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,619,229 Total Patients Enrolled
Honoria M. Guarino, Ph.D.Study DirectorNational Development and Research Institutes, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025